全文获取类型
收费全文 | 1326449篇 |
免费 | 100838篇 |
国内免费 | 2033篇 |
专业分类
耳鼻咽喉 | 19194篇 |
儿科学 | 45810篇 |
妇产科学 | 36139篇 |
基础医学 | 189321篇 |
口腔科学 | 35390篇 |
临床医学 | 115789篇 |
内科学 | 266772篇 |
皮肤病学 | 29271篇 |
神经病学 | 105641篇 |
特种医学 | 53416篇 |
外国民族医学 | 660篇 |
外科学 | 202886篇 |
综合类 | 27224篇 |
现状与发展 | 1篇 |
一般理论 | 403篇 |
预防医学 | 98897篇 |
眼科学 | 28908篇 |
药学 | 98084篇 |
2篇 | |
中国医学 | 2500篇 |
肿瘤学 | 73012篇 |
出版年
2018年 | 14224篇 |
2017年 | 10883篇 |
2016年 | 12088篇 |
2015年 | 13314篇 |
2014年 | 18274篇 |
2013年 | 28240篇 |
2012年 | 38605篇 |
2011年 | 41059篇 |
2010年 | 24372篇 |
2009年 | 22804篇 |
2008年 | 39597篇 |
2007年 | 42343篇 |
2006年 | 42363篇 |
2005年 | 41248篇 |
2004年 | 40259篇 |
2003年 | 39152篇 |
2002年 | 38445篇 |
2001年 | 65719篇 |
2000年 | 68750篇 |
1999年 | 57594篇 |
1998年 | 15564篇 |
1997年 | 14138篇 |
1996年 | 14476篇 |
1995年 | 13679篇 |
1994年 | 12994篇 |
1993年 | 12016篇 |
1992年 | 44759篇 |
1991年 | 43626篇 |
1990年 | 42372篇 |
1989年 | 40329篇 |
1988年 | 37045篇 |
1987年 | 36398篇 |
1986年 | 33794篇 |
1985年 | 32504篇 |
1984年 | 24408篇 |
1983年 | 20482篇 |
1982年 | 11928篇 |
1981年 | 10873篇 |
1980年 | 9695篇 |
1979年 | 21519篇 |
1978年 | 14962篇 |
1977年 | 12682篇 |
1976年 | 11853篇 |
1975年 | 12759篇 |
1974年 | 14776篇 |
1973年 | 14267篇 |
1972年 | 13033篇 |
1971年 | 11806篇 |
1970年 | 11129篇 |
1969年 | 10112篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
53.
Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience 下载免费PDF全文
P. Wils Y. Bouhnik P. Michetti B. Flourie H. Brixi A. Bourrier M. Allez B. Duclos M. Serrero A. Buisson A. Amiot M. Fumery X. Roblin L. Peyrin‐Biroulet J. Filippi G. Bouguen V. Abitbol B. Coffin M. Simon D. Laharie B. Pariente Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif 《Alimentary pharmacology & therapeutics》2018,47(5):588-595
54.
55.
56.
Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey 下载免费PDF全文
57.
Proton pump inhibitors are associated with accelerated development of cirrhosis,hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES 下载免费PDF全文
D. K. Li P. Yan A‐B. Abou‐Samra R. T. Chung A. A. Butt 《Alimentary pharmacology & therapeutics》2018,47(2):246-258
58.
Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis 下载免费PDF全文
59.
Serum pepsinogen 1 and anti‐Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males 下载免费PDF全文
60.
Eyal Schwartzberg Joseph P. Nathan Sivan Avron Eli Marom 《Israel journal of health policy research》2018,7(1):59
The community pharmacy setting is a venue that is readily accessible to the public. In addition, it is staffed by a pharmacist, who is a healthcare provider, trained and capable of delivering comprehensive pharmaceutical care. As such, community pharmacists have a colossal opportunity to serve as key contributors to patients’ health by ensuring appropriate use of medications, preventing medication misadventures, identifying drug-therapy needs, as well as by being involved in disease management, screening, and prevention programs. This unique position gives the pharmacist the privilege and duty to serve patients in roles other than solely that of the stereotypical drug dispenser.Worldwide, as well as in Israel, pharmacists already offer a variety of pharmaceutical services and tend to patients’ and the healthcare system’s needs. This article provides examples of professional, clinical or other specialty services offered by community pharmacists around the world and in Israel and describes these interventions as well as the evidence for their efficacy. Examples of such activities which were recently introduced to the Israeli pharmacy landscape due to legislative changes which expanded the pharmacist’s scope of practice include emergency supply of medications, pharmacists prescribing, and influenza vaccination. Despite the progress already made, further expansion of these opportunities is warranted but challenging. Independent prescribing, as practiced in the United Kingdom or collaborative drug therapy management programs, as practiced in the United States, expansion of vaccination programs, or wide-spread recognition and reimbursement for medication therapy management (MTM) programs are unrealized opportunities. Obstacles such as time constraints, lack of financial incentives, inadequate facilities and technology, and lack of professional buy-in, and suggested means for overcoming these challenges are also discussed. 相似文献